marijuana

A congressional committee has advanced a bill aimed at protecting children online that could create complications for advertisers trying to promote legal marijuana and other regulated substances. Rep. Gus Bilirakis (R-FL) filed the Kids Online Safety Act (KOSA) earlier this month, and the House Energy and Commerce Subcommittee on Commerce, Manufacturing, and Trade approved an…

President Donald Trump on Monday confirmed that the administration is “very strongly” considering a proposal to federally reschedule marijuana because it would boost research into the effects of cannabis. “We are” weighing rescheduling, Trump told reporters after being asked about the issue at an unrelated signing ceremony. He added that “a lot of people want…

Only six percent of marijuana consumers approve of the Trump administration’s actions on cannabis policy to date, according to a new survey that comes as rumors churn that the president intends to direct federal cannabis rescheduling. The latest iteration of a quarterly presidential approval tracking poll from NuggMD and Marijuana Moment also found that 51…

A major drug testing industry organization is “sounding the alarm” amid reports that President Donald Trump may soon finalize a proposal to reschedule marijuana, arguing that the reform would “have catastrophic consequences for the safety of the United States workforce and transportation sectors.” Ahead of a scheduled “National Conversation on the Rescheduling of Marijuana” webinar…

A former top state marijuana regulator and current executive at a cannabis consulting firm will participate in a Senate committee hearing on banking issues this week. While attention within the cannabis community is largely focused on a potentially imminent marijuana rescheduling decision by President Donald Trump, the Senate Banking Subcommittee on Financial Institutions and Consumer…

President Donald Trump publicly acknowledged on Monday that his administration is actively considering reclassifying cannabis under federal law, saying the current Schedule I status blocks medical and scientific research. “A lot of people want to see it, the reclassification, because it leads to tremendous amounts of research that can’t be done unless you reclassify,” Trump…